Development of Innovative Multistage Nanovectors for Cancer Immunotherapy

Flavia Fontana

University of Helsinki

Flavia Fontana received her MSc in Pharmacy (2014) from the University of Pavia, Italy. She is currently a second year graduate student at the Faculty of Pharmacy, University of Helsinki, in Dr. Santos' research group. Her thesis work focuses on the development of innovative nanovectors as vaccines for cancer immunotherapy by microfluidics.


Introduction Cancer is a very challenging disease and new approaches are sought to help in its treatment. Cancer immunotherapy involves the patient’s own immune system in the fight against the tumors using antibodies... [ view full abstract ]


  1. Flavia Fontana (University of Helsinki)
  2. Mohammad-Ali Shahbazi (University of Helsinki)
  3. Dongfei Liu (University of Helsinki)
  4. Hongbo Zhang (University of Helsinki)
  5. Ermei Mäkilä (University of Turku)
  6. Jarno Salonen (University of Turku)
  7. Jouni Hirvonen (University of Helsinki)
  8. Helder A. Santos (University of Helsinki)

Topic Areas

Nanomedecine for cancer diagnosis & therapy , Microfluidics in nanomedicine and nanobiology


OS1-103 » Nanomedecine for cancer diagnosis & therapy (16:00 - Wednesday, 28th September, Tower 24 - Room 103)

Presentation Files

The presenter has not uploaded any presentation files.